BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 23824147)

  • 21. PD1-CD28 Fusion Protein Enables CD4+ T Cell Help for Adoptive T Cell Therapy in Models of Pancreatic Cancer and Non-hodgkin Lymphoma.
    Rataj F; Kraus FBT; Chaloupka M; Grassmann S; Heise C; Cadilha BL; Duewell P; Endres S; Kobold S
    Front Immunol; 2018; 9():1955. PubMed ID: 30214445
    [No Abstract]   [Full Text] [Related]  

  • 22. Analysis of PD-1 and Tim-3 expression on CD4
    Koohini Z; Hossein-Nataj H; Mobini M; Hosseinian-Amiri A; Rafiei A; Asgarian-Omran H
    Clin Rheumatol; 2018 Aug; 37(8):2063-2071. PubMed ID: 29626269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Programmed death 1 expression on HIV-specific CD4+ T cells is driven by viral replication and associated with T cell dysfunction.
    D'Souza M; Fontenot AP; Mack DG; Lozupone C; Dillon S; Meditz A; Wilson CC; Connick E; Palmer BE
    J Immunol; 2007 Aug; 179(3):1979-87. PubMed ID: 17641065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynamics of Expression of Programmed Cell Death Protein-1 (PD-1) on T Cells After Allogeneic Hematopoietic Stem Cell Transplantation.
    Simonetta F; Pradier A; Bosshard C; Masouridi-Levrat S; Dantin C; Koutsi A; Tirefort Y; Roosnek E; Chalandon Y
    Front Immunol; 2019; 10():1034. PubMed ID: 31156625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impairment of the programmed cell death-1 pathway increases atherosclerotic lesion development and inflammation.
    Bu DX; Tarrio M; Maganto-Garcia E; Stavrakis G; Tajima G; Lederer J; Jarolim P; Freeman GJ; Sharpe AH; Lichtman AH
    Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1100-7. PubMed ID: 21393583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Programmed Death Ligand 1 Plays a Neuroprotective Role in Experimental Autoimmune Neuritis by Controlling Peripheral Nervous System Inflammation of Rats.
    Ding Y; Han R; Jiang W; Xiao J; Liu H; Chen X; Li X; Hao J
    J Immunol; 2016 Nov; 197(10):3831-3840. PubMed ID: 27798164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The common gamma-chain cytokines IL-2, IL-7, IL-15, and IL-21 induce the expression of programmed death-1 and its ligands.
    Kinter AL; Godbout EJ; McNally JP; Sereti I; Roby GA; O'Shea MA; Fauci AS
    J Immunol; 2008 Nov; 181(10):6738-46. PubMed ID: 18981091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mycoplasma bovis-Induced Inhibition of Bovine Peripheral Blood Mononuclear Cell Proliferation Is Ameliorated after Blocking the Immune-Inhibitory Programmed Death 1 Receptor.
    Suleman M; Cyprian FS; Jimbo S; Maina T; Prysliak T; Windeyer C; Perez-Casal J
    Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29311234
    [No Abstract]   [Full Text] [Related]  

  • 29. PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2.
    Carter L; Fouser LA; Jussif J; Fitz L; Deng B; Wood CR; Collins M; Honjo T; Freeman GJ; Carreno BM
    Eur J Immunol; 2002 Mar; 32(3):634-43. PubMed ID: 11857337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PD-1/PD-L pathway inhibits M.tb-specific CD4
    Shen L; Gao Y; Liu Y; Zhang B; Liu Q; Wu J; Fan L; Ou Q; Zhang W; Shao L
    Sci Rep; 2016 Dec; 6():38362. PubMed ID: 27924827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PD-1, but not PD-L1, expressed by islet-reactive CD4+ T cells suppresses infiltration of the pancreas during type 1 diabetes.
    Pauken KE; Jenkins MK; Azuma M; Fife BT
    Diabetes; 2013 Aug; 62(8):2859-69. PubMed ID: 23545706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BATF Potentially Mediates Negative Regulation of PD-1/PD-Ls Pathway on T Cell Functions in
    Liu Q; Ou Q; Shen L; Qiu C; Zhang B; Zhang W; Shao L; Gao Y; Chen ZW
    Front Immunol; 2019; 10():2430. PubMed ID: 31681314
    [No Abstract]   [Full Text] [Related]  

  • 33. Blockade of programmed death receptor-1 signaling restores expression of mostly proinflammatory cytokines in anergic cytomegalovirus-specific T cells.
    Dirks J; Egli A; Sester U; Sester M; Hirsch HH
    Transpl Infect Dis; 2013 Feb; 15(1):79-89. PubMed ID: 23176118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Programmed cell death-1 (PD-1) and T-cell immunoglobulin mucin-3 (Tim-3) regulate CD4+ T cells to induce Type 2 helper T cell (Th2) bias at the maternal-fetal interface.
    Wang S; Zhu X; Xu Y; Zhang D; Li Y; Tao Y; Piao H; Li D; Du M
    Hum Reprod; 2016 Apr; 31(4):700-11. PubMed ID: 26908841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human umbilical vein endothelial cells promote the inhibitory activation of CD4(+)CD25(+)Foxp3(+) regulatory T cells via PD-L1.
    Chen WJ; Hu XF; Yan M; Zhang WY; Mao XB; Shu YW
    Atherosclerosis; 2016 Jan; 244():108-12. PubMed ID: 26615520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Augmented expression of programmed death-1 in both neoplastic and non-neoplastic CD4+ T-cells in adult T-cell leukemia/lymphoma.
    Shimauchi T; Kabashima K; Nakashima D; Sugita K; Yamada Y; Hino R; Tokura Y
    Int J Cancer; 2007 Dec; 121(12):2585-90. PubMed ID: 17721918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PD-1/PD-L Pathway Potentially Involved in ITP Immunopathogenesis.
    Nie M; Liu Y; Li XX; Min YN; Yang DD; Li Q; Feng Q; Hou Y; Li GS; Sun JZ; Hou M; Shi Y
    Thromb Haemost; 2019 May; 119(5):758-765. PubMed ID: 30808044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PD-1 and PD-L1 expression on T-cell subsets in women with unexplained recurrent pregnancy losses.
    Wang WJ; Salazar Garcia MD; Deutsch G; Sung N; Yang X; He Q; Jubiz G; Bilal M; Dambaeva S; Gilman-Sachs A; Beaman K; Kwak-Kim J
    Am J Reprod Immunol; 2020 May; 83(5):e13230. PubMed ID: 32086851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PD-L1, PD-1, CD4, and CD8 expression in neoplastic and nonneoplastic thymus.
    Marchevsky AM; Walts AE
    Hum Pathol; 2017 Feb; 60():16-23. PubMed ID: 27746267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. OX40 stimulation and PD-L1 blockade synergistically augment HBV-specific CD4 T cells in patients with HBeAg-negative infection.
    Jacobi FJ; Wild K; Smits M; Zoldan K; Csernalabics B; Flecken T; Lang J; Ehrenmann P; Emmerich F; Hofmann M; Thimme R; Neumann-Haefelin C; Boettler T
    J Hepatol; 2019 Jun; 70(6):1103-1113. PubMed ID: 30826436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.